Price
Target price
€28.50
€28.50
-4.900%
-1.48
-4.900%
€59.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Schott Pharma AG & Co. Kgaa Stock
Schott Pharma AG & Co. Kgaa took a tumble today and lost -€1.480 (-4.900%).
The community is currently still undecided about Schott Pharma AG & Co. Kgaa with 2 Buy predictions and 0 Sell predictions.
With a target price of 59 € there is potential for a 107.02% increase which would mean more than doubling the current price of 28.5 € for Schott Pharma AG & Co. Kgaa.
Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
EQS-News: SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
EQS-News: SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations